Feasibility Trial of the Circumferential Abdominal Pelvic Pressure Device (CAPP)

Postpartum Hemorrhage Clinical Trial

Official title:

Feasibility Trial of the Circumferential Abdominal Pelvic Pressure Device (CAPP)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01497756
• Other study ID #: 10-229
• Status: Completed
• Phase: N/A
• Start date: August 2011
• Est. completion date: May 2012

Study information

• Verified date: February 2020
• Source: University of New Mexico
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

A group of midwives and obstetric nurses have been trained to use circumferential abdominal pelvic pressure (CAPP) to treat postpartum hemorrhage. As part of the training follow up any use of a CAPP device will be monitored to identify complications.

Description:

Providers will be surveyed twice at 4 and 8 months using open ended methods.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 10
• Est. completion date: May 2012
• Est. primary completion date: May 2012
• Accepts healthy volunteers: No
• Gender: Female
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Any patient receiving CAPP during study period.

Exclusion Criteria:

• None (CAPP is only clinically indicated for obstetric hemorrhage post delivery.

Related Conditions & MeSH terms

• Hemorrhage
• Postpartum Hemorrhage

Intervention

Device:
• CAPP use
Any abdominal pelvic pressure

Locations

Country	Name	City	State
United States	University of New Mexico	Albuquerque	New Mexico

Sponsors (1)

Lead Sponsor	Collaborator
University of New Mexico

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Usage	Number of patients on whom CAPP is used	Eight months
Secondary	Side Effects	Any recorded complications	Eight months